High-throughput enrichment and isolation of megakaryocyte progenitor cells from the mouse bone marrow

Lucas M Bush1, Connor P Healy1, James E Marvin2

  • 1Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, 84112, USA.

Scientific Reports
|April 16, 2021
PubMed

Insights

Researchers developed a high-throughput method to identify and isolate megakaryocyte progenitor cells using thrombopoietin (TPO) induction, image flow cytometry, and principal component analysis (PCA). This advances the study of blood cell development and related diseases.

Area of Science:

  • Hematology
  • Cell Biology
  • Biotechnology

Background:

  • Megakaryocytes are crucial for platelet production, essential for hemostasis.
  • Studying megakaryocyte development and diseases is hindered by challenges in identifying and isolating progenitor cells.
  • Hematopoiesis involves complex cell differentiation pathways, including megakaryopoiesis.

Purpose of the Study:

  • To develop a high-throughput strategy for identifying and isolating megakaryocyte progenitor cells.
  • To distinguish megakaryocyte progenitors from other lineage-committed cells.
  • To enable rapid disease identification and diagnosis in megakaryocyte-related disorders.

Main Methods:

  • Coupling thrombopoietin (TPO) induction with image flow cytometry and principal component analysis (PCA).
  • Utilizing a combination of markers and characteristics identified via image flow cytometry and PCA.
  • Applying standard flow cytometry methods for cell isolation based on identified markers.

Main Results:

  • Successful identification and enrichment of megakaryocyte progenitor cells from heterogeneous bone marrow samples.
  • Distinguished megakaryocyte progenitors from other lineage-committed cells in a high-throughput manner.
  • Identified specific markers and characteristics for isolating megakaryocyte progenitor cells.

Conclusions:

  • The developed strategy enables high-throughput enrichment and isolation of megakaryocyte lineage cells.
  • This approach has the potential to accelerate disease identification and diagnosis.
  • Advances in megakaryocyte progenitor cell isolation can impact the understanding and treatment of related hematological disorders.

Related Concept Videos